The kinin system in rhinitis and asthma

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Clinical reviews in allergy and immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02737656PMID 9926285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of nasal mucosal responsiveness to neuronal stimulation in non‐allergic and allergic rhinitis: effects of capsaicin nasal challenge

  1998cited by this paper
• Stable Expression of the Human Kinin B1 Receptor in Chinese Hamster Ovary Cells

  1997cited by this paper
• The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657

  1997cited by this paper
• Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657.

  1997cited by this paper
• Airway responsiveness to bradykinin is related to eosinophilic inflammation in asthma.

  1996cited by this paper
• Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase

  1996cited by this paper
• Origin of late phase histamine release.

  1996cited by this paper
• The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics.

  1996cited by this paper
• Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus.

  1996cited by this paper
• Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma.

  1996cited by this paper
• Dissociation of bradykinin-induced plasma exudation and reactivity in the peripheral airways.

  1996cited by this paper
• Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma.

  1996cited by this paper
• Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes.

  1996cited by this paper
• Allergen-induced hyperresponsiveness to bradykinin is more pronounced than that to methacholine.

  1995cited by this paper
• Bradykinin-induced contraction of human peripheral airways mediated by both bradykinin beta 2 and thromboxane prostanoid receptors.

  1995cited by this paper
• Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action.

  1995cited by this paper
• Synthetic inhibitors of tissue kallikrein: effects in vivo in a model of allergic inflammation.

  1994cited by this paper
• Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds.

  1994cited by this paper
• Contractile effects of bradykinin on the isolated human small bronchus.

  1994cited by this paper
• Perennial rhinitis subjects have altered vascular, glandular, and neural responses to bradykinin nasal provocation.

  1994cited by this paper
• Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen‐induced nasal blockage

  1994cited by this paper
• Glucocorticoids do not alter peptidase expression on a human bronchial epithelial cell line.

  1994cited by this paper
• Effects of ipratropium bromide on bradykinin nasal provocation in chronic allergic rhinitis

  1994cited by this paper
• Localization of immunoreactive tissue kallikrein in human trachea.

  1993cited by this paper
• An in vitro study of the properties of single vagal afferents innervating guinea‐pig airways.

  1993cited by this paper
• Factors determining bradykinin bronchial responsiveness and refractoriness in asthma.

  1993cited by this paper
• Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge.

  1992cited by this paper
• Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist.

  1992cited by this paper
• Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions.

  1992cited by this paper
• Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype.

  1991cited by this paper
• Comparative nasal effects of bradykinin, kallidin and [Des‐Arg9]‐bradykinin in atopic rhinitic and normal volunteers.

  1991cited by this paper
• A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin.

  1991cited by this paper
• Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes.

  1991cited by this paper
• Upper respiratory tract environmental tobacco smoke sensitivity.

  1991cited by this paper
• Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studies

  1991cited by this paper
• A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep.

  1991cited by this paper
• Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies

  1991cited by this paper
• Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy.

  1990cited by this paper
• Kinins are generated in nasal secretions during natural rhinovirus colds.

  1990cited by this paper
• A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers

  1990cited by this paper
• A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection.

  1990cited by this paper
• A bradykinin-antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep.

  1990cited by this paper
• Contribution of histamine and prostanoids to bronchoconstriction provoked by inhaled bradykinin in atopic asthma

  1990cited by this paper
• Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects.

  1990cited by this paper
• Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.

  1990cited by this paper
• Kinins are generated in nasal secretions during influenza A infections in ferrets.

  1990cited by this paper
• Bradykinin-induced bronchoconstriction in guinea pig in vivo: role of neural mechanisms.

  1990cited by this paper
• Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo.

  1990cited by this paper
• Vascular effects of topically applied bradykinin on the human nasal mucosa.

  1990cited by this paper
• Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects.

  1990cited by this paper
• Induction of histamine release from human skin mast cells by bradykinin analogs.

  1989cited by this paper
• Inhibition of human bronchial kallikrein in asthma.

  1989cited by this paper
• The effects of H1 antihistamines on the early allergic response.

  1989cited by this paper
• Localization of glandular kallikrein in nasal mucosa of allergic and nonallergic individuals.

  1989cited by this paper
• Effect of bradykinin on airway ciliary motility and its modulation by neutral endopeptidase.

  1989cited by this paper
• Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation.

  1988cited by this paper
• Kinins are generated during experimental rhinovirus colds.

  1988cited by this paper
• Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat.

  1988cited by this paper
• Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects.

  1987cited by this paper
• Bradykinin-induced bronchoconstriction in humans. Mode of action.

  1987cited by this paper
• Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis.

  1987cited by this paper
• Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis.

  1986cited by this paper
• Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions.

  1986cited by this paper
• Bradykinin stimulates Cl secretion and prostaglandin E2 release by canine tracheal epithelium.

  1985cited by this paper
• Mediator release during nasal provocation. A model to investigate the pathophysiology of rhinitis.

  1985cited by this paper
• Inflammatory mediators in late antigen-induced rhinitis.

  1985cited by this paper
• Influx of kininogens into nasal secretions after antigen challenge of allergic individuals.

  1985cited by this paper
• Electrical properties of monolayers cultured from cells of human tracheal mucosa.

  1985cited by this paper
• Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.

  1983cited by this paper
• Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs.

  1980cited by this paper
• Effect of kallidin, substance P, and other basic polypeptides on the production of respiratory macromolecules.

  1977cited by this paper
• In vivo and in vitro effect of bradykinin on bronchial motor tone in normal subjects and patients with airways obstruction.

  1973cited by this paper
• Kinin-like activity in nasal secretions of allergic patients.

  1970cited by this paper
• The effect of inhalations of bradykinin on healthy and atopic (asthmatic) children.

  1968cited by this paper
• Circulating plasma kinin in patients with bronchial asthma

  1967cited by this paper
• Rhinovirus infections in an industrial population. I. The occurrence of illness.

  1966cited by this paper
• THE ACTION AND ANTAGONISM OF KININS ON BRONCHIOLES

  1963cited by this paper
• Actions of some peptides on bronchial muscle.

  1962cited by this paper
• Actions of pure bradykinin

  1960cited by this paper
• Formation of bradykinin in anaphylactic and peptone shock.

  1950cited by this paper
• Formation of bradykinin in anaphylactic and peptone shock.

  1950cited by this paper

• Humoral First-Line Mucosal Innate Defence in vivo

  2020cites this paper
• Kininogen deficiency or depletion reduces enhanced pause independent of pulmonary inflammation in a house dust mite-induced murine asthma model.

  2019cites this paper
• Airways exudation of plasma macromolecules: Innate defense, epithelial regeneration, and asthma

  2018cites this paper
• Kallikrein-related peptidases in lung diseases

  2018cites this paper
• Bradykinin B2 receptor expression in the bronchial mucosa of allergic asthmatics: the role of NF‐kB

  2016cites this paper
• Kinin B1 receptor antagonist BI113823 reduces allergen-induced airway inflammation and mucus secretion in mice.

  2016cites this paper
• Pathophysiology of Clinical Symptoms in Acute Viral Respiratory Tract Infections

  2015cites this paper
• Pharmacological Modulation of the Bradykinin-Induced Differentiation of Human Lung Fibroblasts: Effects of Budesonide and Formoterol

  2012cites this paper
• Targeting the kallikrein-related peptidases for drug development.

  2012cites this paper
• The Rising Role of TRPA1 in Asthma

  2010cites this paper
• The Rising Role of TRPA 1 in Asthma

  2010cites this paper
• Coughing Precipitated by Bordetella pertussis Infection

  2009cites this paper
• Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases.

  2009cites this paper
• Regulation of kinin B2 receptors by bradykinin in human lung cells

  2008cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update

  2008cites this paper
• Lung cysteine cathepsins: intruders or unorthodox contributors to the kallikrein-kinin system?

  2008cites this paper
• 3'-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression.

  2006cites this paper
• Pathophysiology of nasal obstruction and meta‐analysis of early and late effects of levocetirizine

  2006cites this paper
• Regulator of Gene Expression

  2005cites this paper
• Cathepsin K: a cysteine protease with unique kinin-degrading properties.

  2004cites this paper
• Ethanol Causes Inflammation in the Airways by a Neurogenic and TRPV1-Dependent Mechanism

  2004cites this paper
• Effect of FK3657, a non-peptide bradykinin B2 receptor antagonist, on allergic airway disease models.

  2003cites this paper
• Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone.

  2003cites this paper
• The single mediator approach to asthma therapy: is it so unreasonable?

  2003cites this paper
• The single mediator approach to asthma therapy: is it so unreasonable?

  2003cites this paper
• In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN11270

  2002cites this paper
• Regulation of kinin receptors in airway epithelial cells by inflammatory cytokines and dexamethasone.

  2002cites this paper
• Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release.

  2002cites this paper
• In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.

  2002cites this paper
• Chapter 25 – Kinins

  2002cites this paper
• The "in vivo" and "ex vivo" roles of cylcooxygenase-2, nuclear factor-kappaB and protein kinases pathways in the up-regulation of B1 receptor-mediated contraction of the rabbit aorta.

  2001cites this paper
• Kinin receptors in pain and inflammation.

  2001cites this paper
• Bradykinin B1 receptor up-regulation by interleukin-1beta and B1 agonist occurs through independent and synergistic intracellular signaling mechanisms in human lung fibroblasts.

  2001cites this paper
• Kinin receptors and their antagonists as novel therapeutic agents.

  2001cites this paper
• Allergic rhinitis and its impact on asthma.

  2001cites this paper
• Exudation of plasma and production of thromboxane in human bronchi after local bradykinin challenge.

  2001cites this paper
• Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.

  2001cites this paper
• Asthma Mediators: Current Views

  2000influential citation
• Advances in immunopharmacology of asthma.

  2000cites this paper
• Effect of bradykinin on membrane properties of guinea pig bronchial parasympathetic ganglion neurons.

  2000cites this paper